6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T19112L | Sacubitril Enantiomer | 2R,4S-Sacubitril,ahu377 isomer 2 | Others |
Sacubitril Enantiomer (ahu377 isomer 2) is the enantiomer of Sacubitril which is a neprilysin inhibitor. | |||
T19114L | Sacubitril-(2S,4S)-Isomer | (2S,4S)-Sacubitril | Others |
Sacubitril-(2S,4S)-Isomer ((2S,4S)-Sacubitril) is the isomer of Sacubitril which is a neprilysin inhibitor. | |||
T19112 | 2R,4S-Sacubitril | Sacubitril Enantiomer,ahu377 isomer 2 | Others |
2R,4S-Sacubitril (Sacubitril Enantiomer) is the impurity of Sacubitril which is a neprilysin inhibitor. | |||
T19114 | (2S,4S)-Sacubitril | Sacubitril Impurity C | Others |
(2S,4S)-Sacubitril (Sacubitril Impurity C) is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor. | |||
T2318 | Sacubitril/Valsartan | Sacubitril mixture with Valsartan,Valsartan,Sacubitril,LCZ696 | Apoptosis , RAAS , Neprilysin |
Sacubitril/Valsartan (LCZ696) is an orally bioavailable, dual angiotensin II receptor and neprilysin inhibitor for the treatment of hypertension and heart failure. | |||
T4574L | Sacubitril sodium | AHU377,AHU-377,LCZ696,AHU 377 | |
Sacubitril is an angiotensin receptor neprilysin inhibitor being studied for use in combination with valsartan for heart failure. Sacubitril is a prodrug that is activated to LBQ657 by de-ethylation via esterases. |